AC Immune SA
NASDAQ:ACIU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
US |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
Abbvie Inc
NYSE:ABBV
|
US |
|
Apple Inc
NASDAQ:AAPL
|
US |
Wall St Price Targets
ACIU Price Targets Summary
AC Immune SA
According to Wall Street analysts, the average 1-year price target for
ACIU is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACIU's stock price target?
Price Target
9.18
USD
According to Wall Street analysts, the average 1-year price target for
ACIU is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for AC Immune SA?
Projected CAGR
101%
Over the last 11 years, the compound annual growth rate for Revenue has been -18%. The projected CAGR for the next 5 years is 101%.